218 related articles for article (PubMed ID: 28900428)
1. C-Reactive Protein Binds to Cholesterol Crystals and Co-Localizes with the Terminal Complement Complex in Human Atherosclerotic Plaques.
Pilely K; Fumagalli S; Rosbjerg A; Genster N; Skjoedt MO; Perego C; Ferrante AMR; De Simoni MG; Garred P
Front Immunol; 2017; 8():1040. PubMed ID: 28900428
[TBL] [Abstract][Full Text] [Related]
2. PTX3 as a paradigm for the interaction of pentraxins with the complement system.
Inforzato A; Doni A; Barajon I; Leone R; Garlanda C; Bottazzi B; Mantovani A
Semin Immunol; 2013 Feb; 25(1):79-85. PubMed ID: 23747040
[TBL] [Abstract][Full Text] [Related]
3. Multimer formation and ligand recognition by the long pentraxin PTX3. Similarities and differences with the short pentraxins C-reactive protein and serum amyloid P component.
Bottazzi B; Vouret-Craviari V; Bastone A; De Gioia L; Matteucci C; Peri G; Spreafico F; Pausa M; D'Ettorre C; Gianazza E; Tagliabue A; Salmona M; Tedesco F; Introna M; Mantovani A
J Biol Chem; 1997 Dec; 272(52):32817-23. PubMed ID: 9407058
[TBL] [Abstract][Full Text] [Related]
4. Regulation of the Complement System by Pentraxins.
Haapasalo K; Meri S
Front Immunol; 2019; 10():1750. PubMed ID: 31428091
[TBL] [Abstract][Full Text] [Related]
5. Heterocomplexes of mannose-binding lectin and the pentraxins PTX3 or serum amyloid P component trigger cross-activation of the complement system.
Ma YJ; Doni A; Skjoedt MO; Honoré C; Arendrup M; Mantovani A; Garred P
J Biol Chem; 2011 Feb; 286(5):3405-17. PubMed ID: 21106539
[TBL] [Abstract][Full Text] [Related]
6. Structure and function of the long pentraxin PTX3 glycosidic moiety: fine-tuning of the interaction with C1q and complement activation.
Inforzato A; Peri G; Doni A; Garlanda C; Mantovani A; Bastone A; Carpentieri A; Amoresano A; Pucci P; Roos A; Daha MR; Vincenti S; Gallo G; Carminati P; De Santis R; Salvatori G
Biochemistry; 2006 Sep; 45(38):11540-51. PubMed ID: 16981714
[TBL] [Abstract][Full Text] [Related]
7. Three pentraxins C-reactive protein, serum amyloid p component and pentraxin 3 mediate complement activation using Collectin CL-P1.
Roy N; Ohtani K; Hidaka Y; Amano Y; Matsuda Y; Mori K; Hwang I; Inoue N; Wakamiya N
Biochim Biophys Acta Gen Subj; 2017 Feb; 1861(2):1-14. PubMed ID: 27864148
[TBL] [Abstract][Full Text] [Related]
8. Biochemical and functional characterization of the interaction between pentraxin 3 and C1q.
Nauta AJ; Bottazzi B; Mantovani A; Salvatori G; Kishore U; Schwaeble WJ; Gingras AR; Tzima S; Vivanco F; Egido J; Tijsma O; Hack EC; Daha MR; Roos A
Eur J Immunol; 2003 Feb; 33(2):465-73. PubMed ID: 12645945
[TBL] [Abstract][Full Text] [Related]
9. Serum amyloid P component binds to histones and activates the classical complement pathway.
Hicks PS; Saunero-Nava L; Du Clos TW; Mold C
J Immunol; 1992 Dec; 149(11):3689-94. PubMed ID: 1431140
[TBL] [Abstract][Full Text] [Related]
10. Interaction of C1q With Pentraxin 3 and IgM Revisited: Mutational Studies With Recombinant C1q Variants.
Bally I; Inforzato A; Dalonneau F; Stravalaci M; Bottazzi B; Gaboriaud C; Thielens NM
Front Immunol; 2019; 10():461. PubMed ID: 30923526
[TBL] [Abstract][Full Text] [Related]
11. The tissue pentraxin PTX3 limits C1q-mediated complement activation and phagocytosis of apoptotic cells by dendritic cells.
Baruah P; Dumitriu IE; Peri G; Russo V; Mantovani A; Manfredi AA; Rovere-Querini P
J Leukoc Biol; 2006 Jul; 80(1):87-95. PubMed ID: 16617159
[TBL] [Abstract][Full Text] [Related]
12. Pentraxins in Complement Activation and Regulation.
Ma YJ; Garred P
Front Immunol; 2018; 9():3046. PubMed ID: 30619374
[TBL] [Abstract][Full Text] [Related]
13. The prototypic tissue pentraxin PTX3, in contrast to the short pentraxin serum amyloid P, inhibits phagocytosis of late apoptotic neutrophils by macrophages.
van Rossum AP; Fazzini F; Limburg PC; Manfredi AA; Rovere-Querini P; Mantovani A; Kallenberg CG
Arthritis Rheum; 2004 Aug; 50(8):2667-74. PubMed ID: 15334483
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of genes for C-reactive protein and related pentraxin/complement proteins in photodynamic therapy-treated human tumor cells: enrolment of PI3K/Akt and AP-1.
Merchant S; Korbelik M
Immunobiology; 2013 Jun; 218(6):869-74. PubMed ID: 23182717
[TBL] [Abstract][Full Text] [Related]
15. Collectin CL-P1 utilizes C-reactive protein for complement activation.
Roy N; Ohtani K; Matsuda Y; Mori K; Hwang I; Suzuki Y; Inoue N; Wakamiya N
Biochim Biophys Acta; 2016 Jun; 1860(6):1118-28. PubMed ID: 26922829
[TBL] [Abstract][Full Text] [Related]
16. Pentraxin-3-mediated complement activation in a swine model of renal ischemia/reperfusion injury.
Divella C; Stasi A; Franzin R; Rossini M; Pontrelli P; Sallustio F; Netti GS; Ranieri E; Lacitignola L; Staffieri F; Crovace AM; Lucarelli G; Ditonno P; Battaglia M; Daha MR; van der Pol P; van Kooten C; Grandaliano G; Gesualdo L; Stallone G; Castellano G
Aging (Albany NY); 2021 Apr; 13(8):10920-10933. PubMed ID: 33875620
[TBL] [Abstract][Full Text] [Related]
17. Human renal epithelial cells produce the long pentraxin PTX3.
Nauta AJ; de Haij S; Bottazzi B; Mantovani A; Borrias MC; Aten J; Rastaldi MP; Daha MR; van Kooten C; Roos A
Kidney Int; 2005 Feb; 67(2):543-53. PubMed ID: 15673302
[TBL] [Abstract][Full Text] [Related]
18. C-reactive protein in myocardial infarction binds to circulating microparticles but is not associated with complement activation.
van der Zee PM; Biró E; Trouw LA; Ko Y; de Winter RJ; Hack CE; Sturk A; Nieuwland R
Clin Immunol; 2010 Jun; 135(3):490-5. PubMed ID: 20138585
[TBL] [Abstract][Full Text] [Related]
19. The long pentraxin PTX3 in vascular pathology.
Mantovani A; Garlanda C; Bottazzi B; Peri G; Doni A; Martinez de la Torre Y; Latini R
Vascul Pharmacol; 2006 Nov; 45(5):326-30. PubMed ID: 17023219
[TBL] [Abstract][Full Text] [Related]
20. The long pentraxin PTX3: a modulator of the immunoinflammatory response in atherosclerosis and cardiovascular diseases.
Norata GD; Garlanda C; Catapano AL
Trends Cardiovasc Med; 2010 Feb; 20(2):35-40. PubMed ID: 20656213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
